<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00497913</url>
  </required_header>
  <id_info>
    <org_study_id>85-02-53-4207</org_study_id>
    <nct_id>NCT00497913</nct_id>
  </id_info>
  <brief_title>DysportÂ® Injection in the Treatment of Chronic Lateral Epicondylitis</brief_title>
  <acronym>DCLE</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Tehran University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tehran University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a single injection of Dysport with a new
      protocol at forearm is effective in the management of chronic lateral epicondylitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Some studies valued the effectiveness of botulinum toxin. There is a great amount of
      controversy on the amount of botulinum toxin injected and the location of the injection. The
      purpose of the study is to compare the effectiveness of botulinum toxin injection with
      placebo at a new injection site at the forearm in the treatment of chronic tennis elbow
      unrelieved by corticosteroid injection and physiotherapy. It is a double blind randomized
      controlled trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score on VAS at maximal grip, at maximal pinch, and during previous month at rest</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients subjective feeling of improvement.</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tenderness on lateral epicondyle</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain sensation on resisted wrist extension, and passive wrist flexion</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain-free grip strength, and pinch strength</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal grip strength, and pinch strength</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Tennis Elbow</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NaCl 0.9%</intervention_name>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum Toxin A</intervention_name>
    <arm_group_label>A</arm_group_label>
    <other_name>Dysport</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pain: pain will be assessed as the physician touches lateral epicondyle or passively
             flexing the patient's wrist and while the patient extends his/her wrist or 3rd finger
             against resistance. Individuals who fulfill two or more of above will be considered to
             have lateral epicondylitis.

          -  Symptom duration: should be at least 6 months.

          -  Previous trial of complete course of physiotherapy and corticosteroid injection.

        Exclusion Criteria:

          -  Rheumatoid arthritis

          -  Generalized polyarthritis

          -  Local elbow arthritis

          -  Simultaneous medial epicondylalgia

          -  Bilateral lateral epicondylitis

          -  Neurologic deficits (abnormal light touch sensation, deep tendon reflexes abnormality,
             radicular pain, radial nerve entrapment, signs of nerve root compression, decreased
             muscle force, multiple sclerosis, seizures)

          -  The use of corticosteroid in last 30 days

          -  Simultaneous use of drugs other than acetaminophen or physical therapy in the course
             of study

          -  Pregnancy

          -  Breast-feeding

          -  Previous hand surgery

          -  Having a hobby or job that needs finger extension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seyed Mohammad J Mortazavi, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Tehran University of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Imam Khomeini Hospital</name>
      <address>
        <city>Tehran</city>
        <zip>1419173341</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>April 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2007</study_first_submitted>
  <study_first_submitted_qc>July 6, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2007</study_first_posted>
  <last_update_submitted>April 22, 2008</last_update_submitted>
  <last_update_submitted_qc>April 22, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 23, 2008</last_update_posted>
  <keyword>Tennis Elbow</keyword>
  <keyword>Botulinum Toxin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tennis Elbow</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

